Ecocardiografía de estrés en 2018. 30 años no es nada... Parte I
DOI:
https://doi.org/10.37615/retic.v1n3a3Palabras clave:
isquemia, eco de estrés, dipiridamol, dobutamina, deformación miocárdica, reserva coronaria.Resumen
La ecocardiografía de estrés cuenta hoy una creciente aceptación en la comunidad médica, dado su carácter no invasivo y la ausencia de irradiación, con elevado valor diagnóstico y pronóstico. Puede realizarse con diversas modalidades, esencialmente con ejercicio y fármacos. No se encuentra limitado al análisis de la motilidad parietal valorando en forma confiable la velocidad de flujo coronario, gradientes y reflujos valvulares, así como la presión en arteria pulmonar. La evaluación de la motilidad parietal puede ayudarse de la utilización con criterio del Doppler tisular y especialmente de la deformación por strain 2D. Proponemos una revisión integral de la técnica. En una primera parte se abordará la descripción general del método, los hitos históricos en su desarrollo y el estado actual del arte. A través de casos se intentará mostrar una visión integral de la respuesta cardiovascular al estrés en la enfermedad coronaria y en la evaluación de riesgo.
Descargas
Métricas
Citas
Sicari R, Nihoyannopoulos P, Evangelista A, et al. European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008; 9: 415-437, Eur Heart J. 2009; 30 :278-289.
Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG; American Society of Echocardiography. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007; 20 (9): 1.021-1.041.
Lancellotti P, Pellikka PA, Budts W et al. The Clinical Use of Stress Echocar- diography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017 (2): 101-138.
Picano E. Stress Echocardiography. Sixth Edition Springer. 2015.
Armstrong WF, Zoghbi WA. Stress echocardiography: current methodology and clinical applications. Am Coll Cardiol. 2005. 7; 45 (11): 1.739-1.747.
Mason SJ, Weiss JL, Weisfeldt ML et al. Exercise echocardiography in detection of wall motion Abnormalities during ischemia. Circulation 1979; 59: 50.
Wann LS, Faris JV, Childress RH, Dillon JC, Weyman AE, Feigenbaum H. Exercise cross-sectional echocardiography in ischemic heart disease. Circulation 1979; 60: 1.300.
Picano E, Distante A, Masini M, et al. Dipyridamole-echocardiography test in effort angina pectoris. Am J Cardiol. 1985, 1; 56 (7): 452-456.
Berthe C, Pierard L, Hiernaux M, Trotteur G, et al. Predicting the extend and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infarction. Am J Cardiol. 1986; 58: 1.167-1.172.
Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol. 1978; 41 (2): 267-278.
Mason JR, Palac RT, Freeman MC, et al. Thallium scintigraphy during dobutamine. Am Heart J. 1984, 107: 481-485.
Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. Circulation. 1995, 1; 92 (9): 2.391-2.395.
Izcovich E, Lowenstein J. et al. Detección de pacientes con alto riesgo post IAM mediante el test de dobutamina. XII Congreso Internacional de Cardiología y XIV Congreso de la Sociedad Brasileña de Cardiología 23-28 julio de 1989. Río, Brasil.
Lowenstein J, Izcovich E, et al. Estudio comparativo entre 2 diferentes apremios farmacológicos (dipiridamol y dobutamina) con control Eco 2D para la detección de miocardio isquémico en la etapa precoz post IAM . XVI Congreso Argentino de Cardiología y XIV Congreso Sudamericano de Cardiología. Octubre de 1989.
Lowenstein J, Pellegrini C, Izcovich E, Canet C, Boughen R. Detección mediante el test Eco 2D dobutamina de los pacientes con alto riesgo post infarto agudo de miocardio Rev. Arg de Cardiol 1993; 61; 62-72.
Lowenstein J, Izcovich E, Boughen R, Pellegrini C. Pharmacological 2-D echo stress test for detection of ischemia in the early phase after acute myocardial infarction, Dypiridamole or Dobutamine? Abstract 1° International Symposium Stress Eco Pisa Italy. Enero 1993. Echocardiography. 1995, 12 (3), 328.
Restrepo G, Lowenstein J, Gutierrez Fajardo P y el Grupo de trabajo sobre acreditación de la asociación de ecocardiografía de la sociedad interamericana de cardiología (ECOSIAC): Guías de Acreditación en Ecocardiografía del Adulto y del Laboratorio de Ecocardiografía de la Asociación de Ecocardiografía de la Sociedad Interamericana de Cardiología (ECOSIAC). Rev Arg Cardiol. 2011; 75: 461-472.
Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol. 1999; 34: 1.769-1.777.
Pingitore A, Picano E, Colosso MQ et al. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol. 1996; 27 (5): 1.164-1.170.
Picano E, Sicari R, Landi P, et al. The multicentre trial philosophy in stress echocardiography: lessons learned from the EPIC study. EPIC-EDIC Study Project. Echo Persantine International Cooperative Study. Echo-Dobuta-mine International Cooperative Study. Eur Heart J. 1995; 16 Suppl J: 2-4. Review.
Shamim M. Badruddin. Supine bicycle versus post–treadmill exercise echocardiography in the detection of myocardial ischemia: a randomized single-blind crossover trial. J Am Coll of Cardiol. 1999, 33; 1.485-1.490.
Park TH, Tayan N, Takeda K. et al. Supine bicycle echocardiography improved diagnostic accuracy and physiologic assessment of coronary artery disease with the incorporation of intermediate stages of exercise. J Am Coll Cardiol. 2007, 6; 50 (19): 1.857-1.863.
Caiati C, Lepera ME, Carretta D, Santoro D, Favale S. Head-to-head comparison of peak upright bicycle and post-treadmill echocardiography in detecting coronary artery disease: a randomized, single-blind crossover study. J Am Soc Echocardiogr. 2013; 26 (12): 1.434-1.443.
Garbi M, Chambers J, Vannan MA, Lancellotti P. Valve Stress Echocardiography: A Practical Guide for Referral, Procedure, Reporting, and Clinical Implementation of Results From the HAVEC Group. JACC Cardiovasc Imaging. 2015; 8 (6): 724-736.
Picano E, Molinaro S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound. 2008, 19; 6: 30.
Pratali L, Otasevic P, Neskovic A, et al. Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test. J Card Fail. 2007; 13 (10) : 836-842.
Picano E, Ostojic M, Varga A. et al. Combined low dose dipyridamole-dobu-tamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol. 1996; 27 (6): 1.422-1.428.
Spina S. Ecocardiografía de estrés. Ecocardiografía de estrés con apremios no convencionales capítulo 32 Libro pag785-798. Ecocardiografía e imagen cardiovascular en la práctica clínica, Editorial Distribuna, 2015.
Jamal F, Szilard M, Kukulski T, et al. Changes in systolic and postsystolic wall thickening during acute coronary occlusion and reperfusion in closedchest pigs: Implications for the assessment of regional myocardial function. J Am Soc Echocardiogr. 2001; 14 (7): 691-697.
Doval H. Criterio de “utilización apropiada” de las imágenes cardíacas: ¿el “uso apropiado” de las pruebas diagnósticas es similar a su utilidad clínica? Revista Argentina de Cardiologia 2014. 82; 2, 172-176.
Galderisi M, Mele D, Marino PN. Study Group of Echocardiography of the Italian Society of Cardiology. Quantitation of stress echocardiography by tissue Doppler and strain rate imaging: a dream come true? Ital Heart J. 2005 Jan; 6 (1): 9-20.
Peteiro J, Bouzas-Mosquera A, Broullón J, et al. Hallazgos diagnósticos y pronósticos en pacientes con prueba de esfuerzo clínica o ECG positivos pero ecocardiografía negativa. Rev Española de Cardiologia. https://doi.org/10.1016/j.recesp.2017.01.017.
Kobal SL, Wilkof-Segev R, Patchett MS et al. Prognostic value of myocardial ischemic electrocardiographic response in patients with normal stress echocardiographic study. Am J Cardiol. 2014, 15; 113 (6): 945-949.
Noguchi Y, Nagata-Kobayashi S, Stahl JE, Wong JB. A meta-analytic comparison of echocardiographic stressors. Int J Cardiovasc Imaging. 2005; 21 (2-3): 189-207.
Beleslin BD, Ostojic M, et al. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation. 1994; 90 (3): 1.168-1.176.
Olmos LI, Dakik H, Gordon R. et al. Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation. 1998. 15; 98 (24): 2.679-2.686.
Hoque A, Maaieh M, Longaker RA, Stoddard MF. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5-and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr. 2002; 15 (11): 1.326-1.334.
Araujo AC, Santos BF, Calasans FR, et al. Physical Stress Echocardiography: Prediction of Mortality and Cardiac Events in Patients with Exercise Test showing Ischemia. Arq Bras Cardiol. 2014; 103 (5): 418-425.
Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007. 16; 49 (2): 227-237.
Jeetley P, Burden L, Stoykova B, Senior R. Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study. Eur Heart J. 2007; 28 (2): 204-211.
Bouzas-Mosquera A, Peteiro J, Alvarez-García N et al. Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing. J Am Coll Cardiol. 2009, 26; 53 (21).
Severino S, Dandrea A, Caso P, Celentano E et al. Long-term prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. Ital Heart J. 2001; 2 (4): 256-264.
San Román JA, Vilacosta I, Castillo JA, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996 ; 110 (5): 1.248-1.254.
Severi S, Picano E, Michelassi C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation. 1994; 89 (3): 1.160-1.173.
Pérez de Isla L, Zamorano J, Almería C, et al. Long-term prognostic importance of transient left ventricular dilation during pharmacologic stress echocardiography. J Am Soc Echocardiogr. 2005; 18 (1): 57-62.
Vasey CG, Usedom JE, Woodard SM, et al. Prediction of cardiac mortality after myocardial infarction: the role of maximal treadmill stress echocardio- graphy. J Am Soc Echocardiogr. 2001; 14 (1): 38-43.
Picano E, Lattanzi F, Sicari R, et al. Role of stress echocardiography in risk stratification early after an acute myocardial infarction. EPIC (Echo Persantin International Cooperative) and EDIC (Echo Dobutamine International Coo- perative) Study Groups. Eur Heart J. 1997; 18 Suppl D: D78-85.
Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation. 1997, 18; 95 (6): 1.402-1.410.
Sicari R, Ripoli A, Picano E, et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: A large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group. Circulation. 1999; 100.
Zamorano J, Duque A, Baquero M, Moreno R, et al. Stress echocardiography in the pre-operative evaluation of patients undergoing major vascular surgery. Are results comparable with dypiridamole versus dobutamine stress echo? Rev Esp Cardiol. 2002; 55 (2): 121-126.
Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003, 89 (11): 1.327- 1.334.
Van Damme H, Larbuisson R, Limet R. Preoperative cardiac risk evaluation of vascular surgery patients. Rev Med Liege. 2003; 58 (6): 409-414.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2018 Jorge A. Lowenstein, Víctor Darú
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
RETIC se distribuye bajo la licencia Creative Commons Reconocimiento-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0 que permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
- Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
- No comercial: no puede utilizar el material con fines comerciales.
- No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
- Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
